Screening and Treatment Program to Eliminate Hepatitis C in Egypt

N Engl J Med. 2020 Mar 19;382(12):1166-1174. doi: 10.1056/NEJMsr1912628.

Authors

Imam Waked¹, Gamal Esmat¹, Aisha Elsharkawy¹, Magdy El-Serafy¹, Wael Abdel-Razek¹, Reham Ghalab¹, Galal Elshishiney¹, Aysam Salah¹, Soad Abdel Megid¹, Khaled Kabil¹, Manal H El-Sayed¹, Hany Dabbous¹, Yehia El Shazly¹, Mohamed Abo Sliman¹, Khalid Abou Hashem¹, Sayed Abdel Gawad¹, Nevine El Nahas¹, Ahmed El Sobky¹, Sahar El Sonbaty¹, Hamdy El Tabakh¹, Ehab Emad¹, Hany Gemeah¹, Amal Hashem¹, Mohamed Hassany¹, Naseif Hefnawy¹, Abdel N Hemida¹, Ayman Khadary¹, Kamal Labib¹, Faisal Mahmoud¹, Said Mamoun¹, Tamer Marei¹, Saad Mekky¹, Alsayeda Meshref¹, Alaa Othman¹, Omnia Ragab¹, Elhag Ramadan¹, Ahmed Rehan¹, Tarek Saad¹, Ramy Saeed¹, Mohamed Sharshar¹, Hesham Shawky¹, Mohamed Shawky¹, Wael Shehata¹, Hanaa Soror¹, Mohsen Taha¹, Mahmoud Talha¹, Adel Tealaab¹, Mohamed Zein¹, Alaa Hashish¹, Ahmed Cordie¹, Yasser Omar¹, Ehab Kamal¹, Islam Ammar¹, Mohamed AbdAlla¹, Wafaa El Akel¹, Wahid Doss¹, Hala Zaid¹

Affiliation

¹ From the Hepatology Department, National Liver Institute, Menoufia University, Shebeen El Kom (I.W., W.A.-R.), and the Endemic Medicine Department, Faculty of Medicine, Cairo University (G. Esmat, A.E., M.E.-S., A.C., W.E.A., W.D.), the Ministry of Health and Population (R.G., G. Elshishiney, A.S., S.A.M., M.A.S., K.A.H., S.A.G., N.E.N., A.E.S., S.E.S., H.E.T., E.E., H.G., A. Hashem, N.H., A.N.H., A.K., K.L., F.M., S. Mamoun, T.M., S. Mekky, A.M., A.O., O.R., E.R., A.R., T.S., R.S., M. Sharshar, H. Shawky, M. Shawky, W.S., H. Soror, M. Taha, M. Talha, A.T., M.Z., H.Z.), the National Committee for Control of Viral Hepatitis (K.K.), the Pediatrics Department (M.H.E.-S.), the Hepatology and Tropical Medicine Department (H.D.), and the Department of Medicine (Y.E.S., Y.O.), Ain Shams University, the Hepatology Department, National Hepatology and Tropical Medicine Research Institute (M.H.), the Communicable Diseases Control Cluster, World Health Organization (A. Hashish), the Medical Research Division, National Research Center (E.K., M.A.), and the Tropical Medicine Department, Al-Azhar University (I.A.), Cairo - all in Egypt.

PMID: 32187475
DOI: 10.1056/NEJMsr1912628

No abstract available

MeSH terms

Adolescent
Adult
Antiviral Agents / economics
Antiviral Agents / therapeutic use*
Carbamates
Egypt / epidemiology
Female
Health Care Costs / statistics & numerical data*
Hepatitis C, Chronic / diagnosis*
Hepatitis C, Chronic / drug therapy*
Hepatitis C, Chronic / epidemiology
Hepatitis C, Chronic / prevention & control
Humans
Imidazoles / economics
Imidazoles / therapeutic use*
Male
Mass Screening* / economics
Mass Screening* / methods
Middle Aged
Pyrrolidines
Seroepidemiologic Studies
Sofosbuvir / economics
Sofosbuvir / therapeutic use
Valine / analogs & derivatives
Young Adult

Substances

Antiviral Agents
Carbamates
Imidazoles
Pyrrolidines
Valine
daclatasvir
Sofosbuvir

Grants and funding

001/WHO_/World Health Organization/International